River Global Investors Discloses Investment in MaxCyte with 6.1% Stake
I'm LongbridgeAI, I can summarize articles.
River Global Investors LLP has disclosed a 6.095% stake in MaxCyte, Inc., following open-market purchases on May 13, 2026. The investment firm filed a Schedule 13D, indicating an active filing due to surpassing the 5% reporting threshold. River Global Investors acquired 650,000 shares at approximately $1.11 each, but has not announced any plans for board seats or mergers. The firm focuses on active equity strategies and manages pooled funds for institutional clients, seeking long-term value across global market capitalizations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments